Merck Investors Cut Claims In Securities Fraud MDL

Law360, New York (June 18, 2013, 3:22 PM EDT) -- Several Allianz Global Investors units and Swedish national pension fund Fjarde AP-fonden have dismissed their claims in a multidistrict litigation claiming Merck & Co. and its executives misrepresented arthritis painkiller Vioxx to inflate Merck stock, say documents filed Tuesday in New Jersey federal court.

U.S. District Judge Stanley R. Chesler signed off on the voluntary dismissals, which bars Fjarde AP-fonden, Allianz Global Investors Luxembourg SA, Allianz Global Investors Ireland Ltd. and Allianz Global Investors Kapitalanlagegesellschaft mbH from filing future actions arising out of their dismissed claims....
To view the full article, register now.